Skip to content

Drug interactions

Hydroxychloroquine + Ublituximab

Severity: Minor

Hydroxychloroquine and Ublituximab: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Ublituximab depletes B cells and causes prolonged immunosuppression, with risk of infections. Hydroxychloroquine is only mildly immunomodulatory and is not clearly additive in infection risk. Any added effect is likely small.

What this interaction means in plain words

Hydroxychloroquine and Ublituximab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Hydroxychloroquine belongs to Musculoskeletal; Ublituximab belongs to Miscellaneous.

Evidence level: Low

Why it happens

Possible modest additive immunomodulation; not well established.

What to do

No change is required. Monitor for infection as is routine with ublituximab.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Hydroxychloroquine and Ublituximab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Hydroxychloroquine with Ublituximab?

MediHelp rates the interaction as minor. Hydroxychloroquine and Ublituximab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Ublituximab depletes B cells and causes prolonged immunosuppression, with risk of infections. Hydroxychloroquine is only mildly immunomodulatory and is not clearly additive in infection risk. Any added effect is likely small.

How serious is the interaction between Hydroxychloroquine and Ublituximab?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No change is required. Monitor for infection as is routine with ublituximab.

What other medicines interact with Hydroxychloroquine?

MediHelp also lists interactions of Hydroxychloroquine with, for example, Arsenic trioxide, Cisapride, Dronedarone. The full list is on the Hydroxychloroquine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in